COVID-19 highlights the acute need for non-invasive, point-of-care, remote monitoring

hemodynamic measurement solutions. Find out how CPS meets the need.

Sensydia in the news

October 1, 2019

Sensydia Appoints Anthony Arnold
as President and Chief Executive Officer

Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function, announced that industry leader Anthony Arnold has been appointed as chief executive officer and president and joins the Board of Directors. Arnold is a pioneer in bioelectronic medicine and surgical navigation and brings more than 20 years of leadership experience from a range of medical technology companies including Smith+Nephew, Medtronic, Boston Scientific and SetPoint Medical.

1100 Glendon Ave., Suite 1715

Los Angeles, CA 90024

info@sensydia.com

 

 

 

 

 


 

© 2020 Sensydia

  • LinkedIn